Cargando…
Gene Remodeling in Type 2 Diabetic Cardiomyopathy and Its Phenotypic Rescue with SERCA2a
BACKGROUND/AIM: Diabetes-associated myocardial dysfunction results in altered gene expression in the heart. We aimed to investigate the changes in gene expression profiles accompanying diabetes-induced cardiomyopathy and its phenotypic rescue by restoration of SERCA2a expression. METHODS/RESULTS: Us...
Autores principales: | Karakikes, Ioannis, Kim, Maengjo, Hadri, Lahouaria, Sakata, Susumu, Sun, Yezhou, Zhang, Weijia, Chemaly, Elie R., Hajjar, Roger J., Lebeche, Djamel |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2714457/ https://www.ncbi.nlm.nih.gov/pubmed/19649297 http://dx.doi.org/10.1371/journal.pone.0006474 |
Ejemplares similares
-
Lung-targeted SERCA2a Gene Therapy: From Discovery to Therapeutic Application in Bleomycin-Induced Pulmonary Fibrosis
por: Bisserier, Malik, et al.
Publicado: (2020) -
Therapeutic Cardiac‐Targeted Delivery of miR‐1 Reverses Pressure Overload–Induced Cardiac Hypertrophy and Attenuates Pathological Remodeling
por: Karakikes, Ioannis, et al.
Publicado: (2013) -
SERCA2a gene transfer prevents intimal proliferation in an organ culture of human internal mammary artery
por: Lipskaia, Larissa, et al.
Publicado: (2012) -
Safety and long-term efficacy of AAV1.SERCA2a using nebulizer delivery in a pig model of pulmonary hypertension
por: Watanabe, Shin, et al.
Publicado: (2018) -
Combination Therapy with STAT3 Inhibitor Enhances SERCA2a-Induced BMPR2 Expression and Inhibits Pulmonary Arterial Hypertension
por: Bisserier, Malik, et al.
Publicado: (2021)